Parthenon Research has published reports on the biotechnology industry, FDA regulation, and company stock recommendations. In addition to the biotechnology and health care industries, he has written research on digital media, consumer products, and diversified companies. In 2011, he was a Senior Author on a report analyzing the changes to the health care system in China. The report looked at the structure of the industry and how it differs from the US and European industries, as well as how different segments within the pharmaceutical industry will perform after recent changes in the new health care environment. The report also compared different exchanges where China-based company stocks trade, and found patterns in their valuations, multiples, and trading behavior.
His interest in Neurology and diseases of aging led him to follow the scientific developments for Alzheimer's disease. Parthenon Research published several reports on companies in the field and Introduction to Alzheimer's Disease and Future Therapies, a report available by request.
Our most recent publications is entitled Targeted Payload Cancer Therapeutics - The Next Generation Emerges. This report looks at new developments in the treatment of cancer. The report describes recent progress, the field of monoclonal antibodies, and the new class of drugs that combines targeting agents with radioactive atoms for effective cancer killing with limited side effects.